(Q28289018)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664532%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

review article

1 reference

title

The growth hormone receptor: mechanism of activation and clinical implications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664532%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664532%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Michael J Waters

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664532%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

English

0 references

publication date

27 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664532%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Endocrinology

8 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664532%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664532%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664532%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

515-525

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664532%20AND%20SRC:MED&resulttype=core&format=json

Cardiovascular risk in patients with growth hormone deficiency: effects of growth hormone substitution

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Clinical, endocrine, and molecular findings in 17beta-hydroxysteroid dehydrogenase type 3 deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Turning the growth hormone receptor on: evidence that hormone binding induces subunit rotation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Functional interaction of common gamma-chain and growth hormone receptor signaling apparatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Height, leg length, and cancer risk: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Mining for JAK-STAT mutations in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Growth hormone receptor is expressed in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Growth hormone regulation of sex-dependent liver gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

How growth hormone controls growth, obesity and sexual dimorphism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Recent advances in growth hormone signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Growth hormone as a cytokine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

In vivo analysis of growth hormone receptor signaling domains and their associated transcripts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

In vivo targeting of the growth hormone receptor (GHR) Box1 sequence demonstrates that the GHR does not signal exclusively through JAK2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Nonalcoholic fatty liver in patients with Laron syndrome and GH gene deletion - preliminary report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Reduced recruitment and survival of primordial and growing follicles in GH receptor-deficient mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Growth hormone promotes skeletal muscle cell fusion independent of insulin-like growth factor 1 up-regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Evidence supporting dual, IGF-I-independent and IGF-I-dependent, roles for GH in promoting longitudinal bone growth.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Differential Effects of Growth Hormone and Insulin-Like Growth Factor I on Colony Formation of Epiphyseal Chondrocytes in Suspension Culture in Rats of Different Ages*

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Exercise increases neural stem cell number in a growth hormone-dependent manner, augmenting the regenerative response in aged mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Growth hormone promotes proliferation of adult neurosphere cultures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Optimal use of growth hormone therapy for maximizing adult height in children born small for gestational age.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Height velocity targets from the national cooperative growth study for first-year growth hormone responses in short children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Growth hormone treatment in short children with chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Recombinant growth hormone for idiopathic short stature in children and adolescents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Wor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Growth response, near-adult height, and patterns of growth and puberty in patients with noonan syndrome treated with growth hormone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Recommendations for the diagnosis and management of Prader-Willi syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Effects of growth hormone treatment on growth in children with juvenile idiopathic arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Potential role of growth factors with particular focus on growth hormone and insulin-like growth factor-1 in the management of chronic kidney disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

The effect of growth hormone replacement on exercise capacity in patients with GH deficiency: a metaanalysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Healthcare utilization, quality of life and patient-reported outcomes during two years of GH replacement therapy in GH-deficient adults--comparison between Sweden, The Netherlands and Germany.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Acromegaly pathogenesis and treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Pegvisomant: current and potential novel therapeutic applications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Does growth hormone drive breast and other cancers?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Human growth hormone and extracellular domain of its receptor: crystal structure of the complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Binding in the growth hormone receptor complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Rational design of potent antagonists to the human growth hormone receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Model for growth hormone receptor activation based on subunit rotation within a receptor dimer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Activation of chimeric and full-length growth hormone receptors by growth hormone receptor monoclonal antibodies. A specific conformational change may be required for full-length receptor signaling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Epitope map for a growth hormone receptor agonist monoclonal antibody, MAb 263.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Prolactin receptor antagonists

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented, hydrophobic motif

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Construction of a fluorescein-responsive chimeric receptor with strict ligand dependency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Efficiency of signalling through cytokine receptors depends critically on receptor orientation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

The influence of domain structures on the signal transduction of chimeric receptors derived from the erythropoietin receptor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

JAK2, but not Src family kinases, is required for STAT, ERK, and Akt signaling in response to growth hormone in preadipocytes and hepatoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

An agonist-induced conformational change in the growth hormone receptor determines the choice of signalling pathway.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Involvement of JAK2 and Src kinase tyrosine phosphorylation in human growth hormone-stimulated increases in cytosolic free Ca2+ and insulin secretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Lyn tyrosine kinase regulates thrombopoietin-induced proliferation of hematopoietic cell lines and primary megakaryocytic progenitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Lyn tyrosine kinase is essential for erythropoietin-induced differentiation of J2E erythroid cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Stimulation of c-Src by prolactin is independent of Jak2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Involvement of the Src kinase Lyn in phospholipase C-gamma 2 phosphorylation and phosphatidylinositol 3-kinase activation in Epo signalling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Prediction of the structure of human Janus kinase 2 (JAK2) comprising JAK homology domains 1 through 7.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Janus kinase 2 determinants for growth hormone receptor association, surface assembly, and signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Autoinhibition of Jak2 tyrosine kinase is dependent on specific regions in its pseudokinase domain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

A gain-of-function mutation of JAK2 in myeloproliferative disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Mechanisms of constitutive activation of Janus kinase 2-V617F revealed at the atomic level through molecular dynamics simulations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Dimerization by a cytokine receptor is necessary for constitutive activation of JAK2V617F.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

A JAK2 interdomain linker relays Epo receptor engagement signals to kinase activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Role of the growth hormone (GH) receptor transmembrane domain in receptor predimerization and GH-induced activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Active conformation of the erythropoietin receptor: random and cysteine-scanning mutagenesis of the extracellular juxtamembrane and transmembrane domains

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

The Asn505 mutation of the c-MPL gene, which causes familial essential thrombocythemia, induces autonomous homodimerization of the c-Mpl protein due to strong amino acid polarity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

A novel nonpeptidyl human c-Mpl activator stimulates human megakaryopoiesis and thrombopoiesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

NMR structural studies of interactions of a small, nonpeptidyl Tpo mimic with the thrombopoietin receptor extracellular juxtamembrane and transmembrane domains.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Partially corrected X-linked severe combined immunodeficiency: long-term problems and treatment options

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

The continuum of growth hormone-IGF-I axis defects causing short stature: diagnostic and therapeutic challenges

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Defects in growth hormone receptor signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

The extracellular domain of the growth hormone receptor interacts with coactivator activator to promote cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Characterisation of novel missense mutations in the GH receptor gene causing severe growth retardation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

A dominant-negative mutation of the growth hormone receptor causes familial short stature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after Box1, resulting in isolated failure of STAT 5 signal transduction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

A novel C-terminal growth hormone receptor (GHR) mutation results in impaired GHR-STAT5 but normal STAT-3 signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Growth hormone insensitivity associated with a STAT5b mutation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Control of growth hormone (GH) binding protein release from human hepatoma cells expressing full-length GH receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

The serum growth hormone binding protein: pregnant with possibilities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Insulin-like growth factor-I treatment in primary growth hormone insensitivity: effect of recombinant human IGF-I (rhIGF-I) and rhIGF-I/rhIGF-binding protein-3 complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Prolactin is a component of the human synovial liquid and modulates the growth and chondrogenic differentiation of bone marrow-derived mesenchymal stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Clinical and biochemical impact of the d3 growth hormone receptor genotype in acromegaly.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Growth patterns and the risk of breast cancer in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: A preliminary report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Advanced rat mammary cancers are growth hormone dependent

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

The role of the IGF system in cancer growth and metastasis: overview and recent insights

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

G-CSF and its receptor in myeloid malignancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

The contribution of growth hormone to mammary neoplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

High stromal and epithelial human gh gene expression is associated with proliferative disorders of the mammary gland

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Increased expression of growth hormone and prolactin receptors in hepatocellular carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Nuclear localization of EGF receptor and its potential new role as a transcription factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Trafficking of receptor tyrosine kinases to the nucleus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Growth hormone therapy in children and adolescents: pharmacokinetic/pharmacodynamic considerations and emerging indications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Growth after organ transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

A review of the effects of growth hormone changes on symptoms of frailty in the elderly with chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Negative regulation of growth hormone receptor signaling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

A 36 residues insertion in the dimerization domain of the growth hormone receptor results in defective trafficking rather than impaired signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.123

Expression of the gene encoding growth hormone in the human mammary gland

31 March 2020

1 reference

12 December 2020

Up-regulation of growth hormone receptor immunoreactivity in human melanoma

1 reference

12 December 2020

Fibromyalgic syndromes: could growth hormone therapy be beneficial?

1 reference

12 December 2020

The role of the WSXWS equivalent motif in growth hormone receptor function.

1 reference

12 December 2020

Growth and growth hormone treatment in short stature children born small for gestational age.

1 reference

12 December 2020

Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH.

1 reference

12 December 2020

Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency

1 reference

12 December 2020

Growth hormone resurrects adult human thymus during HIV-1 infection

1 reference

12 December 2020

Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone

1 reference

12 December 2020

Four contiguous amino acid substitutions, identified in patients with Laron syndrome, differently affect the binding affinity and intracellular trafficking of the growth hormone receptor

1 reference

12 December 2020

The use of hypophysectomy in juvenile diabetes mellitus with vascular complications

1 reference

12 December 2020

Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer

1 reference

12 December 2020

Growth hormone receptor antagonist administration inhibits growth of human colorectal carcinoma in nude mice.

1 reference

12 December 2020

Replacement therapy and cardiovascular diseases.

1 reference

12 December 2020

Insulin-like growth factor-I (rhIGF-I) therapy of short stature

1 reference

12 December 2020

Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway

1 reference

12 December 2020

A novel mutation affecting the interdomain link region of the growth hormone receptor in a Vietnamese girl, and response to long-term treatment with recombinant human insulin-like growth factor-I and luteinizing hormone-releasing hormone analogue

1 reference

12 December 2020

Nuclear translocation and anchorage of the growth hormone receptor.

1 reference

12 December 2020

An antisense oligonucleotide targeting the growth hormone receptor inhibits neovascularization in a mouse model of retinopathy

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2010.123

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664532%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017